A Randomised, Open-label Study to Compare Plasma Concentrations of Aramchol in Healthy Volunteers After Once or Twice Daily Oral Dosing to Steady State
Latest Information Update: 25 Feb 2020
At a glance
- Drugs Icomidocholic acid (Primary)
- Indications Cholelithiasis; Fibrosis; Lipodystrophy; Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis
- Focus Pharmacokinetics
- Sponsors Galmed Pharmaceuticals
- 03 Apr 2019 Status changed from recruiting to completed.
- 12 Mar 2019 According to a Galmed Pharmaceuticals media release, the data from this study were recently submitted to the FDA and will be discussed in the forthcoming end of Phase 2b meeting.
- 12 Mar 2019 Results presented in the Galmed Pharmaceuticals media release.